Unlock New Anti-Tuberculosis Drugs With FadD32 Targeting
Abstract The main and prime objective of this project is to identify new anti-Mycobacterial tuberculosis drugs targeting FadD32 which is a fatty acyl- AMP ligase involved in the biosynthesis of mycolic acids; essential for the survival of Mycobacterium tuberculosis, the causative agent of tuberculosis (Léger et al., 2009). This protein catalyzes the conversion of … Read more